Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey.
Journal
American journal of clinical dermatology
ISSN: 1179-1888
Titre abrégé: Am J Clin Dermatol
Pays: New Zealand
ID NLM: 100895290
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
accepted:
07
07
2021
pubmed:
28
10
2021
medline:
17
2
2022
entrez:
27
10
2021
Statut:
ppublish
Résumé
Acne affects more than 80% of adolescents and young adults, who most often develop acne scars. Supporting data on the effect of acne scars on patient's health-related quality of life (HRQOL) are limited. The aim was to determine how the severity of acne scars impacts the HRQOL of afflicted individuals. In this population-based cross-sectional study, 723 adults with facial acne scars but without active acne lesions self-completed the Self-assessment of Clinical Acne-Related Scars (SCARS) questionnaire formulated to investigate degree of acne scarring. The Facial Acne Scar Quality of Life (FASQoL), Dermatology Life Quality Index (DLQI), and Dysmorphic Concern Questionnaire (DCQ) were completed to assess the attitude of these patients toward their scars and the impact of scarring on their HRQOL. The mean (standard error) DLQI score for facial acne scars was 6.26 (0.22). Acne scars were considered a 'very large' or 'extremely large' concern by 19.3% of participants with mild scars as compared to 20.1% and 34.0% of participants with moderate and severe/very severe scars, respectively (P = 0.003). Higher FASQoL scores were associated with increased severity of scarring (P = 0.001). In total, 16.9% of participants had clinical features of dysmorphia (i.e., DCQ > 13). DCQ scores were significantly higher among participants with more severe scarring (mean DCQ score of 8.04 [0.28], 8.40 [0.18], and 10.13 [0.08] among participants with mild, moderate, and severe/very severe acne scars, respectively; P = 0.001). Most commonly reported signs of emotional distress were self-consciousness (68.0%) and worry about scars not going away (74.8%). This study highlights the significant psychosocial impact of atrophic acne scars in the form of embarrassment and self-consciousness. Individuals with mild scars also expressed significant impact on quality of life that increased with aggravation of scar severity. Patient-reported outcomes provide an insight into the physical, functional, and psychological impact of acne scarring from the patient's perspective.
Sections du résumé
BACKGROUND
BACKGROUND
Acne affects more than 80% of adolescents and young adults, who most often develop acne scars. Supporting data on the effect of acne scars on patient's health-related quality of life (HRQOL) are limited.
OBJECTIVE
OBJECTIVE
The aim was to determine how the severity of acne scars impacts the HRQOL of afflicted individuals.
METHODS
METHODS
In this population-based cross-sectional study, 723 adults with facial acne scars but without active acne lesions self-completed the Self-assessment of Clinical Acne-Related Scars (SCARS) questionnaire formulated to investigate degree of acne scarring. The Facial Acne Scar Quality of Life (FASQoL), Dermatology Life Quality Index (DLQI), and Dysmorphic Concern Questionnaire (DCQ) were completed to assess the attitude of these patients toward their scars and the impact of scarring on their HRQOL.
RESULTS
RESULTS
The mean (standard error) DLQI score for facial acne scars was 6.26 (0.22). Acne scars were considered a 'very large' or 'extremely large' concern by 19.3% of participants with mild scars as compared to 20.1% and 34.0% of participants with moderate and severe/very severe scars, respectively (P = 0.003). Higher FASQoL scores were associated with increased severity of scarring (P = 0.001). In total, 16.9% of participants had clinical features of dysmorphia (i.e., DCQ > 13). DCQ scores were significantly higher among participants with more severe scarring (mean DCQ score of 8.04 [0.28], 8.40 [0.18], and 10.13 [0.08] among participants with mild, moderate, and severe/very severe acne scars, respectively; P = 0.001). Most commonly reported signs of emotional distress were self-consciousness (68.0%) and worry about scars not going away (74.8%).
CONCLUSIONS
CONCLUSIONS
This study highlights the significant psychosocial impact of atrophic acne scars in the form of embarrassment and self-consciousness. Individuals with mild scars also expressed significant impact on quality of life that increased with aggravation of scar severity. Patient-reported outcomes provide an insight into the physical, functional, and psychological impact of acne scarring from the patient's perspective.
Identifiants
pubmed: 34705166
doi: 10.1007/s40257-021-00628-1
pii: 10.1007/s40257-021-00628-1
pmc: PMC8776674
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115-123Informations de copyright
© 2021. The Author(s).
Références
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
J Dermatol. 2005 Sep;32(9):705-10
pubmed: 16361712
J Health Psychol. 2009 Nov;14(8):1105-18
pubmed: 19858331
J Cutan Med Surg. 2007 Nov-Dec;11(6):211-6
pubmed: 18042334
J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50
pubmed: 19376456
Acta Derm Venereol. 2002;82(2):104-7
pubmed: 12125936
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):361-366
pubmed: 27640402
BMJ. 2001 Nov 3;323(7320):1015-6
pubmed: 11691744
Am J Clin Dermatol. 2000 Jan-Feb;1(1):3-17
pubmed: 11702303
Clin Exp Dermatol. 1994 Jul;19(4):303-8
pubmed: 7955470
Br J Dermatol. 1997 Aug;137(2):246-50
pubmed: 9292074
J Drugs Dermatol. 2017 Feb 1;16(2):97-102
pubmed: 28300850
Br J Dermatol. 1999 Feb;140(2):273-82
pubmed: 10233222
Dermatol Ther (Heidelb). 2016 Jun;6(2):219-33
pubmed: 26886873
J Invest Dermatol. 2014 Jun;134(6):1527-1534
pubmed: 24166134
Aust N Z J Psychiatry. 1998 Feb;32(1):129-32
pubmed: 9565194
J Eur Acad Dermatol Venereol. 2001 Nov;15(6):541-5
pubmed: 11843213
J Cutan Aesthet Surg. 2015 Jul-Sep;8(3):153-8
pubmed: 26644739
Br J Dermatol. 2013 Mar;168(3):474-85
pubmed: 23210645
J Hum Lact. 2019 Aug;35(3):413-417
pubmed: 31084575
Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):683-7
pubmed: 22016275
J Am Acad Dermatol. 2003 Jul;49(1 Suppl):S1-37
pubmed: 12833004
Br J Dermatol. 2008 Nov;159(5):997-1035
pubmed: 18795920
Clin Exp Dermatol. 2001 Jul;26(5):380-5
pubmed: 11488820